Nuclear receptors are ligand activated transcription factors, where upon binding
with small molecule ligands, these proteins are involved in the regulation of gene
expression. To date there are approximately 48 human nuclear receptors known, involved
in multiple biological and cellular processes, ranging from differentiation to maintenance
of homeostasis. Due to their critical role in transcriptional regulation, these receptors are
implicated in several diseases. Currently, 13% of prescribed drugs in the market are NR
ligands for diseases such as cancer, diabetes and osteoporosis. In addition to drug discovery, the mechanism of function, mobility and trafficking of these receptors is poorly understood. Gaining insight into the relationship between the function and /or
dysfunction of these receptors and their mobility will aid in a better understanding of the
role of these receptors.
The green fluorescent protein (GFP) has revolutionized molecular biology by
providing the ability to monitor protein function and structure via fluorescence. The
fluorescence contribution from this biological marker is the chromophore, formed from
the polypeptide backbone of three amino acid residues, buried inside 11-stranded â-barrel
protein. Synthesis of GFP derivatives of is based on the structure of the
arylmethyleneimidazolidinone (AMI), creating a molecule that is only weakly fluorescent.
Characterizing these AMI derivatives for other proteins can provide a powerful
visualization tool for analysis of protein function and structure. This development could
provide a very powerful method for protein analysis in vitro and in vivo.
Development of such fluorescent ligands will prove beneficial for the nuclear
receptors.
In this work, libraries of AMIs derviatives were synthesized by manipulating
various R groups around the core structure, and tested for their ability to serve as nuclear
receptor ligands with the ability to fluoresce upon binding. The fluorogens are developed
for steroidal and non-steroidal receptors, two general classes of nuclear receptors.
Specific AMIs were designed and developed for steroid receptor estrogen receptor á
(ERá). These ligands are showed to activate the receptor with an EC50 of value 3 ìM and the 10-fold activation with AMI 1 and AMI 2 in comparison to the 21-fold activation
observed with natural ERá ligand, 17â-estradiol. These novel ligands were not able to
display the fluorescence upon binding the receptor. However, fluorescence localized in
nucleus was observed in case of another AMI derivative, AMI 10, which does not
activate the receptor. Such ligands open new avenues for developing fluorescent probes
for ERá that do not involve fluorescent conjugates attached to a known ERá ligand core.
AMIs were also characterized for non-steroidal receptors,specifically the pregnane x receptor (PXR) and retinoic acid receptor á (RARá). To date, fluorogens which turn fluorescence upon binding and activate the receptor have not been developed for these receptors. With respect to PXR, several AMI derivatives were discovered to bind and activate this receptor with a fold-activation better than the known agonist, rifampicin. The best characterized AMI derivative, AMI 4, activates the receptor with an EC50 of value 6.3 ìM and the 154-fold activation in comparison to the 90-fold activation and an EC50 value of 1.3 ìM seen with rifamipicin. This ligand is not only able to activate PXR but also displays fluorescence upon binding to the receptor. The fluroscence pattern was observed around the nucleus. Besides AMI 4, 16 other AMI derivatives are identified that activate PXR with different activation profiles. Thus, a novel class of PXR ligands with fluorescence ability has been developed. The AMI derivatives able to bind and activate RAR, also displayed activation profiles that were comparable to the wild-type ligand, all trans retinoic acid. These ligands activated the receptor with an EC50 value of 220 nM with AMI 109 in comparison to an EC50 value of 0.8 nM with the natural ligand for RARá. When these ligands were tested for fluorescence in yeast, the yeast were able to fluoresce only in the presence of the receptor and the AMI derivative, indicating that these agonists also have the ability to fluoresce.
| Identifer | oai:union.ndltd.org:GATECH/oai:smartech.gatech.edu:1853/44764 |
| Date | 18 May 2012 |
| Creators | Duraj-Thatte, Anna |
| Publisher | Georgia Institute of Technology |
| Source Sets | Georgia Tech Electronic Thesis and Dissertation Archive |
| Detected Language | English |
| Type | Dissertation |
Page generated in 0.002 seconds